Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Comparative study of proton pump inhibitors].

L Herszényi1, Z Tulassay

  • 1Altalános Orvostudományi Kar, II. Belgyógyászati Klinika, Semmelweis Egyetem, Budapest.

Orvosi Hetilap
|October 30, 2001
PubMed
Summary

Proton pump inhibitors (PPIs) are effective for acid-related disorders. While similar, subtle differences in pharmacokinetics, efficacy, and drug interactions among PPIs warrant consideration for optimal patient treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subjective expectations regarding longevity and future health: a cross-sectional survey among patients with Crohn's disease.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
Same author

Analysis of microRNA expression in brush cytology specimens improves the diagnosis of pancreatobiliary cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2019
Same author

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.

Alimentary pharmacology & therapeutics·2017
Same author

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.

Alimentary pharmacology & therapeutics·2016
Same author

Letter: dermatological complications with therapy for inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2013
Same author

Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.

International journal of immunogenetics·2012

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Proton pump inhibitors (PPIs) have revolutionized acid-related disorder management.
  • PPIs share a common mechanism of action in inhibiting gastric acid secretion.

Purpose of the Study:

  • To review the pharmacokinetic and pharmacodynamic differences between various PPIs.
  • To compare the clinical efficacy and drug interaction profiles of individual PPIs.
  • To guide the selection of appropriate PPIs for specific patient needs.

Main Methods:

  • Literature review of existing clinical trials and pharmacological studies on PPIs.
  • Comparative analysis of pharmacokinetic and pharmacodynamic data.
  • Evaluation of reported clinical outcomes and adverse events associated with different PPIs.

Main Results:

  • Individual PPIs exhibit variations in absorption, metabolism, and elimination.
  • Differences in potency and duration of action exist, potentially impacting efficacy.
  • Potential for drug interactions varies among PPIs, necessitating careful prescribing.

Conclusions:

  • Despite overall similar efficacy, distinct characteristics of PPIs necessitate individualized treatment selection.
  • Further research is required to elucidate the clinical significance of these differences.
  • Optimizing PPI therapy may lead to improved clinical benefits for patients with acid-related disorders.

Related Experiment Videos